3623 results for «2199»

Filter By

3623 results

Hotlines and innovations on other coronary interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:

  • Gender differences in outcomes after rational atherectomy PCI
  • Intensified antiplatelet therapy in post-PCI patients with HOPR
Hotlines and innovations on other coronary interventions - PCR e-Course 2020

Selection of appropriate devices for retrograde CTO cases

25 Jun 2020 – From PCR e-Course 2020

Watch this roundtable discussion if you want to witness appropriate device selection for retrograde approach, to improve your skills as a CTO operator and to have interactive discussions about available chronic total occlusion wires and devices.

Selection of appropriate devices for retrograde CTO cases

Hotlines and innovations on valve interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:

  • Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
  • Quantitative angiographic assessment of MR after mitral procedures
Hotlines and innovations on valve interventions - PCR e-Course 2020

To stent or not to stent? Discussion of complex PCI cases

26 Jun 2020 – From PCR e-Course 2020

Watch this roundtable discussion if you want to join a detailed discussion about the drug-eluting stent vs. drug-coated balloon approach, to discuss the importance of lesion preparation for optimal coronary intervention results and to share insights about state-of-the-art treatment options from leading expert.

To stent or not to stent? Discussion of complex PCI cases

Hotlines and innovations on STEMI - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of STEMI:

  • Stenosis Severity and Complete Revascularisation in STEMI
  • Analysis of changes in decision-making process during OCT-guided PCI
Hotlines and innovations on STEMI - PCR e-Course 2020

Current evidence for the interventional treatment of INOCA patients

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Current evidence for the interventional treatment of INOCA patients

Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how intravascular lithotripsy works through real-world cases, to hear from global leading physicians about where intravascular lithotripsy fits into their clinical practice and to hear about some of the most prominent cases of coronary intravascular lithotripsy.

Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium

Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...

Target all comers outcomes update

Crossover results from the RADIANCE-HTN SOLO trial

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.

Videos included on this page: the Hot Line presentation, an...

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

Update on the regulation of high-risk medical devices: a transatlantic perspective

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.

This session was originally presented during PCR...

Update on the regulation of high-risk medical devices

PICSO improves coronary microvascular function in patients with STEMI

25 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.

Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.

Latest experience with PiCSO in STEMI patients

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

PCR e-Course 2020 Late-Breaking Trials – part 1

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • Crossover results from the RADIANCE-HTN SOLO trial
  • DynamX Bioadaptor, a novel « uncaging » platform
  • Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
PCR e-Course 2020 Late-Breaking Trials

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI
Didn’t find what you were looking for?